Tag: acc.16

January 23, 2017/News & Insights

Distinctive Dozen: 12 Developments from 2016 Likely to Reshape Cardiovascular Practice

Experts weigh in on key advancements from the past year

April 13, 2016/Research

TAVR in Intermediate-Risk Patients: Takeaways from PARTNER 2A and SAPIEN 3 (Video)

Perspectives from leading Cleveland Clinic co-investigators

Diabetes Doesn’t Influence Long-Term Graft Patency After Heart Bypass Surgery
April 11, 2016/News & Insights

Diabetes Doesn’t Influence Long-Term Graft Patency After Heart Bypass

Other factors explain diabetic patients’ poorer outcomes after bypass


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

April 4, 2016/News & Insights

Patient Preference Should Guide Postoperative AF Strategy

No clinical advantage to either rhythm or rate control

April 3, 2016/News & Insights

GAUSS-3 Yields Robust Evidence of Muscle-Related Statin Intolerance

Also finds PCSK9 inhibitor more potent than ezetimibe in statin-intolerant patients

April 3, 2016/News & Insights

ACCELERATE Shows Third Time’s No Charm for CETP Inhibitors

Trial stopped early after evacetrapib fails to budge event rate

STEMI's Evolving Risk Profile
March 31, 2016/News & Insights

How STEMI’s Risk Profile Has Changed Over 20 Years (Infographic)

Risk factors surge as patients grow younger, more obese

March 25, 2016/News & Insights

Don’t Miss These Late-Breaking Trials at ACC.16

Seven high-profile studies ranging from TAVR to lipid-lowering

Critical Limb Ischemia
March 21, 2016/News & Insights

Critical Limb Ischemia: National Snapshot of Its Management Holds a Few Surprises

Endovascular procedures associated with lower mortality, LOS, cost vs. surgical bypass

BackPage 1 of 1Next